The State announced an investment of $130.7 million in state opioid settlement funds to expand harm reduction services and launch new community-based support initiatives for families impacted by substance use.
The new allocation builds on New Jersey’s comprehensive strategy to save lives and promote recovery for those affected by addiction. Funding will support $118.7 million over five and a half years for the continuation and expansion of Harm Reduction Centers, and $12 million over three years in direct grants to family and community support organizations.
The New Jersey Opioid Recovery and Remediation Advisory Council is tasked with making recommendations for the effective use of the State’s share of nationwide settlement agreements with several opioid manufacturers and distributors for their contributions to the ongoing opioid epidemic. The Advisory Council in June issued its five-year Strategic Plan after a 15-month planning and stakeholder engagement process. It includes four key investment areas: housing, harm reduction, treatment, and coordinated wraparound services.
Contact: Paul Penna, Director of Government Affairs, ppenna@njlm.org, 609-695-3481, x110.